Evidence map›Paper›PMID 17118492›Full record

ArticleNeurochemistry international2007

Effects of melatonin and age on gene expression in mouse CNS using microarray analysis.

Edward H Sharman, Stephen C Bondy, Kaizhi G Sharman, Debomoy Lahiri, Carl W Cotman, Victoria M Perreau

Open access · greenAbstract read
In one paragraph

Article in Neurochemistry international, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. α-Arrestins and Their Functions: From Yeast to Human Health.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Attenuation of acute and chronic inflammation using compounds derived from plants.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  8. Article
  9. Article
  10. Mechanisms Underlying Tumor Suppressive Properties of Melatonin.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Nanoparticles and colloids as contributing factors in neurodegenerative disease.International journal of environmental research and public health · 2011
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Edward H SharmanCenter for Occupational and Environmental Health, Department of Community and Environmental Medicine, University of California, Irvine, CA 92697-1825, USA. esharman@uci.edu
Stephen C Bondy
Kaizhi G Sharman
Debomoy Lahiri
Carl W Cotman
Victoria M Perreau
University of California, Irvine · USIndiana University – Purdue University Indianapolis · US

Funding

Neurodegenration and Mitochnodrial Dysfunction in AgingR01AG016794 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BONDY, STEPHEN C · 1999 to 2008
$2.9M
Mechanisms of Cholinesterase Inhibitors on Beta-amyloidR01AG018884 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 2002 to 2012
$2.9M
ALUMINUM/IRON INTERACTIONS IN NEURODEGENERATIVE DISEASER01ES007992 · NIEHS · UNIVERSITY OF CALIFORNIA IRVINE · PI BONDY, STEPHEN C · 1996 to 2005
$2.1M
NONCHOLINERGIC FUNCTIONS OF CHOLINESTERASE INHIBITORSR03AG014882 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LAHIRI, DEBOMOY K · 1997 to 1997
–
NIA NIH HHS AG 14882NIA NIH HHS AG 16794NIA NIH HHS AG 18884NIA NIH HHS R01 AG016794NIA NIH HHS R01 AG018884NIEHS NIH HHS ES 7992NIEHS NIH HHS R01 ES007992
6 · The paper itself

Abstract

The expression levels of a number of genes associated with inflammation and immune function change with advancing age. Melatonin modulates gene expression levels of several of these genes. Therefore the declining levels of melatonin associated with age may play a role in the physiological effects of aging. We used oligonucleotide microarrays to measure age-related changes in mRNA expression in the murine CNS, and to study the effect of prolonged administration of dietary melatonin upon these changes. CB6F1 male mice were fed 40 ppm melatonin for 2.1 months prior to sacrifice at age 26.5 months, and compared with both age-matched controls and young, 4.5-month-old untreated controls. Total RNA was extracted from whole brain (excluding cerebellum and brain stem) and individual samples were hybridized to Affymetrix Mouse 430-2.0 arrays. The expression of a substantial number of genes was modulated by melatonin treatment and changes in selected genes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). A subset of these genes did not change with age. Conversely, some genes modulated by age were also modulated by melatonin treatment. In general, melatonin treatment drove the expression levels of these genes closer to the expression levels detected in the younger animals. Notably, the abundance of lipocalin 2 (Lcn2) mRNA increased with age and was decreased in old animals treated with melatonin. Lcn2 is a member of the acute phase response family of proteins and its mRNA levels in the brain increase in response to inflammation. Many of the genes with expression reduced by melatonin are involved in inflammation and the immune system. This suggests that melatonin treatment may influence the inflammatory responses of old animals, driving them to resemble more closely those occurring in young animals.

Indexed as

Acute-Phase ProteinsAgingAnimalsArylalkylamine N-AcetyltransferaseCentral Nervous SystemGene ExpressionHeat-Shock ProteinsLipocalin-2LipocalinsMelatoninMiceMice, Inbred BALB CMice, Inbred C57BLMolecular Sequence DataOligonucleotide Array Sequence AnalysisOncogene ProteinsAcute-Phase ProteinsArylalkylamine N-AcetyltransferaseHeat-Shock ProteinsLcn2 protein, mouseLipocalin-2LipocalinsMelatoninOncogene ProteinsReceptor, Melatonin, MT1RNA, Messenger

Identifiers

PMID17118492
PMCPMC1868445
OpenAlexW2134065049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.